540 related articles for article (PubMed ID: 31059866)
1. A validated method for the quantification of mitragynine in sixteen commercially available Kratom (Mitragyna speciosa) products.
Fowble KL; Musah RA
Forensic Sci Int; 2019 Jun; 299():195-202. PubMed ID: 31059866
[TBL] [Abstract][Full Text] [Related]
2. Rapid detection by direct analysis in real time-mass spectrometry (DART-MS) of psychoactive plant drugs of abuse: the case of Mitragyna speciosa aka "Kratom".
Lesiak AD; Cody RB; Dane AJ; Musah RA
Forensic Sci Int; 2014 Sep; 242():210-218. PubMed ID: 25086346
[TBL] [Abstract][Full Text] [Related]
3. Suspected Adulteration of Commercial Kratom Products with 7-Hydroxymitragynine.
Lydecker AG; Sharma A; McCurdy CR; Avery BA; Babu KM; Boyer EW
J Med Toxicol; 2016 Dec; 12(4):341-349. PubMed ID: 27752985
[TBL] [Abstract][Full Text] [Related]
4. Comparison of three chromatographic techniques for the detection of mitragynine and other indole and oxindole alkaloids in Mitragyna speciosa (kratom) plants.
Wang M; Carrell EJ; Ali Z; Avula B; Avonto C; Parcher JF; Khan IA
J Sep Sci; 2014 Jun; 37(12):1411-8. PubMed ID: 24659356
[TBL] [Abstract][Full Text] [Related]
5. Comparative Pharmacokinetics of Mitragynine after Oral Administration of Mitragyna speciosa (Kratom) Leaf Extracts in Rats.
Avery BA; Boddu SP; Sharma A; Furr EB; Leon F; Cutler SJ; McCurdy CR
Planta Med; 2019 Mar; 85(4):340-346. PubMed ID: 30452072
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous quantification of ten key Kratom alkaloids in Mitragyna speciosa leaf extracts and commercial products by ultra-performance liquid chromatography-tandem mass spectrometry.
Sharma A; Kamble SH; León F; Chear NJ; King TI; Berthold EC; Ramanathan S; McCurdy CR; Avery BA
Drug Test Anal; 2019 Aug; 11(8):1162-1171. PubMed ID: 30997725
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive methodology for identification of Kratom in police laboratories.
Kowalczuk AP; Łozak A; Zjawiony JK
Forensic Sci Int; 2013 Dec; 233(1-3):238-43. PubMed ID: 24314525
[TBL] [Abstract][Full Text] [Related]
8. Determination of Mitragynine in
Mudge EM; Brown PN
J AOAC Int; 2017 Jan; 100(1):18-24. PubMed ID: 27725074
[TBL] [Abstract][Full Text] [Related]
9. Patterns and reasons for kratom (Mitragyna speciosa) use among current and former opioid poly-drug users.
Singh D; Yeou Chear NJ; Narayanan S; Leon F; Sharma A; McCurdy CR; Avery BA; Balasingam V
J Ethnopharmacol; 2020 Mar; 249():112462. PubMed ID: 31816368
[TBL] [Abstract][Full Text] [Related]
10. Development of indirect competitive ELISA for quantification of mitragynine in Kratom (Mitragyna speciosa (Roxb.) Korth.).
Limsuwanchote S; Wungsintaweekul J; Keawpradub N; Putalun W; Morimoto S; Tanaka H
Forensic Sci Int; 2014 Nov; 244():70-7. PubMed ID: 25216455
[TBL] [Abstract][Full Text] [Related]
11. Kratom (Mitragyna speciosa) Validation: Quantitative Analysis of Indole and Oxindole Alkaloids Reveals Chemotypes of Plants and Products.
Manwill PK; Flores-Bocanegra L; Khin M; Raja HA; Cech NB; Oberlies NH; Todd DA
Planta Med; 2022 Aug; 88(9-10):838-857. PubMed ID: 35468648
[TBL] [Abstract][Full Text] [Related]
12. Metabolite profiling and identification of enzymes responsible for the metabolism of mitragynine, the major alkaloid of
Kamble SH; Sharma A; King TI; León F; McCurdy CR; Avery BA
Xenobiotica; 2019 Nov; 49(11):1279-1288. PubMed ID: 30547698
[TBL] [Abstract][Full Text] [Related]
13. A simple HPLC-DAD method for the detection and quantification of psychotropic mitragynine in Mitragyna speciosa (ketum) and its products for the application in forensic investigation.
Parthasarathy S; Ramanathan S; Murugaiyah V; Hamdan MR; Said MI; Lai CS; Mansor SM
Forensic Sci Int; 2013 Mar; 226(1-3):183-7. PubMed ID: 23385139
[TBL] [Abstract][Full Text] [Related]
14. Accelerated Solvent Extractions (ASE) of
Goh YS; Karunakaran T; Murugaiyah V; Santhanam R; Abu Bakar MH; Ramanathan S
Molecules; 2021 Jun; 26(12):. PubMed ID: 34204457
[No Abstract] [Full Text] [Related]
15. Chemical composition and biological effects of kratom (Mitragyna speciosa): In vitro studies with implications for efficacy and drug interactions.
Todd DA; Kellogg JJ; Wallace ED; Khin M; Flores-Bocanegra L; Tanna RS; McIntosh S; Raja HA; Graf TN; Hemby SE; Paine MF; Oberlies NH; Cech NB
Sci Rep; 2020 Nov; 10(1):19158. PubMed ID: 33154449
[TBL] [Abstract][Full Text] [Related]
16. "Evaluation of ion mobility spectrometry for the detection of mitragynine in kratom products".
Fuenffinger N; Ritchie M; Ruth A; Gryniewicz-Ruzicka C
J Pharm Biomed Anal; 2017 Feb; 134():282-286. PubMed ID: 27951469
[TBL] [Abstract][Full Text] [Related]
17. Correlations of kratom (Mitragyna speciosa Korth.) tea bag preparations and reported pharmacological effects.
Grundmann O; Hill K; Al Barzanji E; Hazrat NG; Kaur G; Negeve RE; Shade S; Weber S; Veltri CA
J Ethnopharmacol; 2023 Dec; 317():116779. PubMed ID: 37364801
[TBL] [Abstract][Full Text] [Related]
18. Lateral Flow Assessment and Unanticipated Toxicity of Kratom.
Smith LC; Lin L; Hwang CS; Zhou B; Kubitz DM; Wang H; Janda KD
Chem Res Toxicol; 2019 Jan; 32(1):113-121. PubMed ID: 30380840
[TBL] [Abstract][Full Text] [Related]
19. Do You Get What You Paid For? An Examination of Products Advertised as Kratom.
Griffin OH; Daniels JA; Gardner EA
J Psychoactive Drugs; 2016; 48(5):330-335. PubMed ID: 27669103
[TBL] [Abstract][Full Text] [Related]
20. Drug testing for mitragynine and kratom: Analytical challenges and medico-legal considerations.
Helander A; Rylski A
Drug Test Anal; 2023 Feb; 15(2):213-219. PubMed ID: 36258649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
